Logo

MDxHealth

MDxHealth Prices $40M Public Offering

The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.

In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More

News items for the week of Jan. 9, 2023.

In Brief This Week: OpGen, MDxHealth, Dante Genomics, More

New items for the week of Oct. 24, 2022.

MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay
Premium

The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points.

In Brief This Week: Genetron, MDxHealth, Biocept, Beckman Coulter, Biocartis, Satio, More

News items for the week of Aug. 22, 2022.

Aug 2, 2022

MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M

Jun 17, 2022

Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth

Mar 3, 2022

MDxHealth Posts 20 Percent Revenue Growth for 2021

Nov 29, 2021

Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy

Nov 12, 2021

In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More

Nov 4, 2021

MDxHealth Prices IPO of American Depositary Shares

Oct 21, 2021

MDxHealth Q3 Revenues Grow 23 Percent

Oct 13, 2021

MDxHealth Files for IPO of American Depositary Shares

Sep 1, 2021

MDxHealth Files for IPO of American Depositary Shares

Aug 26, 2021

MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound

May 21, 2021

Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests

Mar 3, 2021

MDxHealth 2020 Revenues Up 57 Percent

Mar 2, 2021

Oppenheimer Initiates Coverage of MDxHealth at Outperform

Oct 21, 2020

MDxHealth Q3 2020 Revenues Drop 6 Percent

Aug 26, 2020

MDxHealth H1 2020 Revenues Down 9 Percent on Declining Test Volumes

Apr 27, 2020

MDxHealth Receives €12.7M Investment From MVM Partners

Apr 9, 2020

MDxHealth Q1 Revenues Up 24 Percent; Company Suspends 2020 Guidance

Feb 26, 2020

MDxHealth 2019 Revenues Fall 58 Percent

Nov 11, 2019

MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period

Oct 4, 2019

Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.